SPFH2 mediates the endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors and other substrates in mammalian cells

被引:86
作者
Pearce, Margaret M. P.
Wang, Yuan
Kelley, Grant G.
Wojcikiewicz, Richard J. H.
机构
[1] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA
[2] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA
关键词
ER-ASSOCIATED DEGRADATION; PROTEIN-DEGRADATION; UBIQUITIN-LIGASE; DOWN-REGULATION; QUALITY-CONTROL; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; REGULATED UBIQUITINATION; P97-UFD1-NPL4; COMPLEX; RAFT ASSOCIATION; DOMAIN PROTEIN;
D O I
10.1074/jbc.M701862200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inositol 1,4,5-trisphosphate (IP3) receptors are endoplasmic reticulum ( ER) membrane calcium channels that, upon activation, become substrates for the ER-associated degradation (ERAD) pathway. Although it is clear that IP3 receptors are polyubiquitinated upon activation and are transferred to the proteasome by a p97-based complex, currently nothing is known about the proteins that initially select activated IP3 receptors for ERAD. Here, we sought to identify novel proteins that associate with and mediate the ERAD of endogenous activated IP3 receptors. SPFH2, an uncharacterized SPFH domain-containing protein, rapidly associated with IP3 receptors in a manner that preceded significant polyubiquitination and the association of p97 and related proteins. SPFH2 was found to be an ER membrane protein largely residing within the ER lumen and in resting and stimulated cells was linked to ERAD pathway components, apparently via endogenous substrates undergoing degradation. Suppression of SPFH2 expression by RNA interference markedly inhibited IP3 receptor polyubiquitination and degradation and the processing of other ERAD substrates. Overall, these studies identify SPFH2 as a key ERAD pathway component and suggest that it may act as a substrate recognition factor.
引用
收藏
页码:20104 / 20115
页数:12
相关论文
共 64 条
[1]   Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? [J].
Ahner, A ;
Brodsky, JL .
TRENDS IN CELL BIOLOGY, 2004, 14 (09) :474-478
[2]   Involvement of the p97-Ufd1-Npl4 complex in the regulated endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors [J].
Alzayady, KJ ;
Panning, MM ;
Kelley, GG ;
Wojcikiewicz, RJH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (41) :34530-34537
[3]   The versatility and universality of calcium signalling [J].
Berridge, MJ ;
Lipp, P ;
Bootman, MD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) :11-21
[4]   The inositol 1,4,5-trisphosphate receptors [J].
Bezprozvanny, I .
CELL CALCIUM, 2005, 38 (3-4) :261-272
[5]   Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells - Evidence for involvement of the proteasome pathway [J].
Bokkala, S ;
Joseph, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (19) :12454-12461
[6]   Structural insights into the regulatory mechanism Of IP3 receptor [J].
Bosanac, I ;
Michikawa, T ;
Mikoshiba, K ;
Ikura, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1742 (1-3) :89-102
[7]   Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER [J].
Browman, Duncan T. ;
Resek, Mary E. ;
Zajchowski, Laura D. ;
Robbins, Stephen M. .
JOURNAL OF CELL SCIENCE, 2006, 119 (15) :3149-3160
[8]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[9]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[10]   Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins [J].
Carvalho, Pedro ;
Goder, Veit ;
Rapoport, Tom A. .
CELL, 2006, 126 (02) :361-373